These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
964 related articles for article (PubMed ID: 11315990)
21. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. Kim S; Shevde NK; Pike JW J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825 [TBL] [Abstract][Full Text] [Related]
22. The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation. Solomon C; Macoritto M; Gao XL; White JH; Kremer R J Bone Miner Res; 2001 Jan; 16(1):39-45. PubMed ID: 11149488 [TBL] [Abstract][Full Text] [Related]
23. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715 [TBL] [Abstract][Full Text] [Related]
24. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469 [TBL] [Abstract][Full Text] [Related]
25. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895 [TBL] [Abstract][Full Text] [Related]
26. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs. Quack M; Carlberg C Mol Pharmacol; 1999 Jun; 55(6):1077-87. PubMed ID: 10347251 [TBL] [Abstract][Full Text] [Related]
27. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes. Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745 [TBL] [Abstract][Full Text] [Related]
28. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271 [TBL] [Abstract][Full Text] [Related]
29. Previtamin D3 with a trans-fused decalin CD-ring has pronounced genomic activity. Verlinden L; Verstuyf A; Verboven C; Eelen G; De Ranter C; Gao LJ; Chen YJ; Murad I; Choi M; Yamamoto K; Yamada S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R J Biol Chem; 2003 Sep; 278(37):35476-82. PubMed ID: 12829710 [TBL] [Abstract][Full Text] [Related]
30. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor. Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478 [TBL] [Abstract][Full Text] [Related]
32. Resistance of HBL100 human breast epithelial cells to vitamin D action. Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184 [TBL] [Abstract][Full Text] [Related]
33. Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo. Verlinden L; Verstuyf A; Van Camp M; Marcelis S; Sabbe K; Zhao XY; De Clercq P; Vandewalle M; Bouillon R Cancer Res; 2000 May; 60(10):2673-9. PubMed ID: 10825140 [TBL] [Abstract][Full Text] [Related]
34. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene. MacDonald PN; Dowd DR; Nakajima S; Galligan MA; Reeder MC; Haussler CA; Ozato K; Haussler MR Mol Cell Biol; 1993 Sep; 13(9):5907-17. PubMed ID: 8395017 [TBL] [Abstract][Full Text] [Related]
36. Isolation of baculovirus-expressed human vitamin D receptor: DNA responsive element interactions and phosphorylation of the purified receptor. Jurutka PW; MacDonald PN; Nakajima S; Hsieh JC; Thompson PD; Whitfield GK; Galligan MA; Haussler CA; Haussler MR J Cell Biochem; 2002; 85(2):435-57. PubMed ID: 11948698 [TBL] [Abstract][Full Text] [Related]
37. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators. Herdick M; Carlberg C J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027 [TBL] [Abstract][Full Text] [Related]
39. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change. Bula CM; Bishop JE; Ishizuka S; Norman AW Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812 [TBL] [Abstract][Full Text] [Related]
40. Identification of a vitamin D3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene. Kim RH; Li JJ; Ogata Y; Yamauchi M; Freedman LP; Sodek J Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):219-26. PubMed ID: 8761475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]